PAM13- A COST-EFFECTIVENESS MODEL COMPARING CELECOXIB AND ROFECOXIB TO TRADITIONAL NSAIDS FOR OSTEOARTHRITIS TREATMENT
Abstract
Authors
MG Schaefer AP Morreale BK Plowman
MG Schaefer AP Morreale BK Plowman
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now